» Related Searches: cancer patients, patients, Patients, dialysis, aids patients
Results 1 to 10 of 13 
Fee nixed for cab-riding dialysis patients
Greensburg officials won't charge dialysis patients using taxis and making brief
stops at the J. Edward Hutchinson garage to keep appointments at Fresenius Medical Care … 
Incidence and Risk Factors for Hip or Other Bone Fractures …
Hip fracture prevalence and the incidence and risk factors associated with hip and other
fractures in representative groups of hemodialysis facilities and patients are
studied. Kidney International …
Obesity an advantage in MHD patients
Despite significant improvements in dialysis treatments, currently over 20 percent of
the 350,000 maintenance hemodialysis patients in the United States die each year. A
study published in Hemodialysis International finds …
- ├ EU Warns of Obesity Crisis — The Christian Post RSS Feed
- ├ Neurogen Announces Phase I Clinical Trial For … — Health News from Medical News Today
- ├ Europe to draw up strategy against obesity (AFP) — Yahoo! News: Health News
- └ all 10 related »
New Study Confirms WelChol Improves Glycemic Control in Patients With …
Study Presented Today at the American Heart Association's Scientific Sessions 2006 Found
That WelChol Provided Further Reductions in A1C in Patients Uncontrolled on Insulin …
Study Favors TAXUS Stent Over Cypher Stent and Bare-Metal Stents …
Lower re-intervention rates for the TAXUS Stent in diabetic patients …
- ├ Study Favors TAXUS(R) Stent Over Cypher(R) Stent … — PR Newswire: All Releases
- ├ Study may boost bare-metal stents — Boston Globe -- Business News
- ├ Bare Metal Stents: No Longer Passé? — Medscape Cardiology Headlines
- └ all 10 related »
Heart Risk Seen in Drug for Anemia
A new study suggests that high doses of a best-selling drug used to treat anemia in
dialysis and cancer patients may increase the risk of heart problems …
Bad news for top-selling anemia drug
A new medical study suggests that high doses of a best-selling drug used to treat anemia
in dialysis and cancer patients may increase the risk of heart problems and
death …
Bad news for top-selling anemia drugs
… dialysis and cancer patients may increase the risk of heart problems and
death …
New Data Show ACTOS Halted Progression of Atherosclerosis as Indicated …
Results Demonstrated Significant Improvements on Cardiovascular Markers Beyond Glycemic
Control …
- ├ New Data Show ACTOS(R) (pioglitazone HCl) Halted … — ArriveNet : Press Releases
- ├ Takeda Pharmaceuticals North America: New Data Show … — Market Wire - Medical and Healthcare
- ├ New data show ACTOS (pioglitazone HCl) halted … — EurekAlert! - Medicine and Health
- └ all 10 related »
Ruboxistaurin Reduced Vision Loss in Patients With Moderate to Severe …
- Once Daily, Oral Investigational Therapy Reduced Sustained Moderate Vision Loss Over
Three-Year Period - …
- ├ Lilly: Arxxant cuts sight loss in diabetes — United Press International - Health Business
- ├ Lilly drug reduces blindness in diabetic patients — Pharmaceutical Business Review Latest News
- ├ November 8, 2006: In the News — Medscape Headlines
- └ all 10 related »